3-Dimensional Magnetic Resonance Spectroscopic Imaging at 3Â Tesla for Early Response Assessment of Glioblastoma Patients During External Beam Radiation Therapy

Change in mean and median Cho/NAA detected at 3 weeks was a significant predictor of early progression. The potential impact for risk-adaptive therapy based on early spectroscopic findings is suggested.